期刊文献+

乳腺癌组织中FOXO3a、β-Catenin、PCNA的表达及临床意义 被引量:5

Expression and significance of FOXO3a,β-Catenin and PCNA in the tissue of breast cancer
下载PDF
导出
摘要 目的探讨叉头转录因子(FOXO3a)、β-连环素(β-Catenin)、增殖细胞核抗原(PCNA)在乳腺癌发生、发展中的作用。方法选择我院手术切除的乳腺癌组织标本68份(肿瘤组)和乳腺纤维腺瘤组织标本20份(腺瘤组),采用免疫组化Envision两步法检测两组FOXO3a、β-Catenin、PCNA蛋白表达;采用Spearman等级相关分析法分析三指标间及与乳腺癌临床病理参数的相关性。结果肿瘤组、腺瘤组FOXO3a阳性表达率分别为60%9、0%,β-Catenin异常表达率分别为65%、25%,PCNA阳性表达率分别为69%3、5%,两两比较P均<0.05;FOXO3a阳性表达与乳腺癌临床分期、雌激素受体、腋窝淋巴结转移、预后相关,β-Catenin异常表达与乳腺癌组织学分级、腋窝淋巴结转移、临床分期相关,PCNA阳性表达与乳腺癌腋窝淋巴结转移、临床分期相关;乳腺癌组织中FOXO3a阳性表达与β-Catenin异常表达、PCNA阳性表达均呈负相关,β-Catenin异常表达与PCNA阳性表达呈正相关。结论 FOXO3a低表达、β-Catenin异常表达、PCNA高表达与乳腺癌的发生、发展相关。 Objectives To investigate the effects of forkbead transcription factor (FOXO3a), β-Catenin and proliferating cell nuclear antigen (PCNA) in the dvelopment and progression of breast cancer. Methods Expression of FOXO3a, β-Catenin and PCNA in 68 patients with breast cancer (tumor group)and 20 patients with breast fibroadenoma ( adenoma group) were examined by immunohistochemical Envision method. Correlation was then analyzed between the expression of three indexes and major clinicopathologic variables. Rttlts The positive expression rates of FOXO3a in the tumor group and adenoma group were 60% and 90%, the positive expression rates of β-Catenin were 65% and 25%, respectively. And the positive expression rates of PCNA were 69% and 35%, repectively. The comparison between the two groups showed that P 〈0.05. The positive expression of FOXO3a in breast cancer was correlated with the clinical staging, ER, node metastasis and prognosis. The abnormal expression of β-Catenin was correlated with the histologic grade, node metastasis and clinical staging. The positive expression of PCNA was correlated with the node metastasis and clinical staging. The positive expression of FOXO3a was negatively correlated with the abnormal expression of β-Catenin and the positive expression of PCNA, and the abnormal expression of β-Catenin was positively correlated with the positive expression of PCNA. Conclusion Low expression of FOXO3a and high expression of β-Catenin and PCNA were correlated with occurrence and development of breast cancer.
出处 《山东医药》 CAS 北大核心 2011年第27期16-18,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30972937)
关键词 乳腺肿瘤 叉头转录因子 Β-连环素 增殖细胞核抗原 breast cancer forkhead transcription factor β-Catenin proliferating cell nuclear antigen
  • 相关文献

参考文献9

  • 1Tsai KL, Huang CY, Chang CH, et al. Crystal structure of the hu- man FOXKla-DNA complex and its implications on the diverse binding specificity of winged helix/fork head proteins [ J ]. J Biol Chem, 2006,281 (25) : 17400-17409.
  • 2Stroud JC, Wu YM, Bates DL, et al. Structure of the forkhead do- main of FOXP2 bound to DNA[J]. Structure, 2006,14(1) :159- 166.
  • 3Weigelt J, Climent I, Dahlman-Wright K, et al. Solution structure of the DNA binding domain of the human forkhead transcription fac- tor AFX (FOXO4) [J]. Biochem, 2001,40(20) :5861-5869.
  • 4Lau QC, Raja E, Salto-Tellez M, et al. RUNX3 is frequenfly inac- tivated by dual mechanisms of protein mislocalization and promoter hypennethylation in breast cancer[ J]. Cancer Res, 2006,66( 13 ) : 6512-6520.
  • 5Jin GS, Kondo E, Miyake T, et al. Expression and intracellular lo- calization of FKHRL1 in mammary gland neoplasms [ J ]. Acta Med Okayama, 2004,58(4) :197-205.
  • 6Mofin PJ. Beta-Catenin signaling and cancer[ J]. Bioessays, 1999, 21 (12) :1021-1030.
  • 7Polakis P, Wnt signaling and cancer[J]. Genes Dev, 2000, 14 (15) : 1837-1851.
  • 8Torben H, Grete KJ, Karin Z. Correlation of growth fraction by Ki- 67 and proliferatating cell nuclear antigen (PCNA) immunohisto- chemistry with histopathological parameters and prognosis in primary breast carcinomas[J]. Virchows Arch, 1998, (433) :223-228.
  • 9刘君,方志沂,石松魁,郎义芳,宁连胜,傅西林.保乳手术治疗乳腺癌[J].实用癌症杂志,2003,18(4):403-405. 被引量:37

二级参考文献8

  • 1Nold RJ, Beamer RL, Helmer SD, et al. Factors influencing a women's choice to undergo to breast-conserving surgery versus modified radical mastectomy [J]. Am J Surg, 2000,180(6) :413.
  • 2Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute[J]. J Clin Oncol, 1998,16(1) :93.
  • 3Burke MF, Allison R, Tripcony L, et al. Conservative therapy of breast cancer in queensland[J]. Int J Radiat Oncol Biol Phys, 1995,31(2) .295.
  • 4Weber S,Storm FK, Stitt J,et al. The role of frozen section analysis of margins during breast conservation surgery[J]. Cancer J Sci Am, 2000,6 (1) ; 28.
  • 5Kearney TJ, Morrow M. Effect of reexcision on the success of breast conserving surgery [J]. Ann Surg Oncol,1995,2(4) :303.
  • 6Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer:influence of margin status and systemic therapy on local recurrence[J]. J Clin Oncol. 2000. 18(8), 1668.
  • 7于金明,李建彬,孙敏,魏守杰,左文述,王永胜.乳腺癌保留乳房术后放射治疗58例[J].中华放射肿瘤学杂志,1997,6(1):27-30. 被引量:29
  • 8石松魁,郎义芳,傅西林,李瑞英,方志沂,宁连胜,马淑资,李云英,刘俊田,朱元喜.0~Ⅱ期乳腺癌外科保守治疗的疗效观察[J].中国肿瘤临床,2002,29(1):46-48. 被引量:27

共引文献36

同被引文献38

  • 1范志强,姜佑三,徐勇,张彤.PCNA、MMP9和E-cd在膀胱移行上皮癌中表达及意义[J].天津医药,2005,33(7):405-407. 被引量:5
  • 2刘禄成,李香云,范海涛,郭航,张明,王颂.VEGF/VEGFR在膀胱癌中表达的研究[J].中国免疫学杂志,2006,22(7):633-635. 被引量:8
  • 3刘阳,王立国.保乳手术治疗早期乳腺癌的临床分析[J].实用医学杂志,2006,22(20):2411-2412. 被引量:28
  • 4曾柯,吴小候,杜虎.survivin靶向siRNA对膀胱癌细胞增殖和凋亡作用的体外研究[J].重庆医学,2007,36(14):1360-1362. 被引量:4
  • 5Ku JH,Kwak C,Lee HS,et al.Expression of survivin,anovel inhibitor of apoptosis,in superficial transitional cellcarcinoma of the bladder[J].J Urol,2004,171(2Pt 1):631-635.
  • 6Bernardini S,Fauconnet S,Chabannes E,et al.Serum lev-els of vascular endothelial growth factor as a prognosticfactor in bladder cancer[J].J Urol,2001,166(4):1275-1279.
  • 7Mitselou A,Ioachim E,Kitsou E,et al.Immunohisto-chemical study of apoptosis-related Bcl-2protein and itscorrelation with proliferation indices(Ki67,PCNA),tumor suppressor genes(p53,pRb),the oncogene c-erbB-2,sex steroid hormone receptors and other clinico-pathological features,in normal,hyperplastic and neo-plastic endometrium[J].In Vivo,2003,17(5):469-477.
  • 8Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosisgene,survivin,expressed in cancer and lymphoma[J].NatMed,1997,3(8):917-921.
  • 9Lehner R,Lucia MS,Jarboe EA,et al.Immunohistochem-ical localization of the IAP protein survivin in bladder mu-cosa and transitional cell carcinoma[J].Appl Immunohis-tochem Mol Morphol,2002,10(2):134-138.
  • 10Demir R, Dimmler A, Naschberger E, et al. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front [ J ]. Exp Mol Pathol, 2009,87(2) :109-116.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部